136 related articles for article (PubMed ID: 38766988)
21. Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients.
Lee HI; Lim YY; Kim BJ; Kim MN; Min HJ; Hwang JH; Song KY
Dermatol Surg; 2010 Jun; 36(6):885-93. PubMed ID: 20482724
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients.
Jang WS; Lee CK; Kim BJ; Kim MN
Dermatol Surg; 2011 Aug; 37(8):1133-40. PubMed ID: 21585597
[TBL] [Abstract][Full Text] [Related]
23. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of malar dermal melasma with a fractional ablative CO₂ laser in a patient with type V skin.
Neeley MR; Pearce FB; Collawn SS
J Cosmet Laser Ther; 2010 Dec; 12(6):258-60. PubMed ID: 21142733
[TBL] [Abstract][Full Text] [Related]
25. Impact of blue light on skin pigmentation in patients with melasma.
Li L; Jiang X; Tu Y; Yang Y; Zhang X; Gu H; He L
Skin Res Technol; 2023 Jul; 29(7):e13401. PubMed ID: 37522494
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of melasma in Brazilian patients: a multicenter study.
Hexsel D; Lacerda DA; Cavalcante AS; Machado Filho CA; Kalil CL; Ayres EL; Azulay-Abulafia L; Weber MB; Serra MS; Lopes NF; Cestari TF
Int J Dermatol; 2014 Apr; 53(4):440-4. PubMed ID: 23967822
[TBL] [Abstract][Full Text] [Related]
27. A split face randomized controlled trial comparing 1,064 nm Q-switched Nd-YAG laser and modified Kligman's formulation in patients with melasma in darker skin.
Dev T; Sreenivas V; Sharma VK; Sahni K; Bhari N; Sethuraman G
Int J Dermatol; 2020 Dec; 59(12):1525-1530. PubMed ID: 33017045
[TBL] [Abstract][Full Text] [Related]
28. Could 675-nm Laser Treatment Be Effective for Facial Melasma Even in Darker Phototype?
Bonan P; Verdelli A; Pieri L; Fusco I
Photobiomodul Photomed Laser Surg; 2021 Oct; 39(10):634-636. PubMed ID: 34597175
[No Abstract] [Full Text] [Related]
29. Melanocyte activation and skin barrier disruption induced in melasma patients after 1064 nm Nd:YAG laser treatment.
Gao YL; Jia XX; Wang M; Hua Y; Zheng H; Xiang WZ; Song XZ
Lasers Med Sci; 2019 Jun; 34(4):767-771. PubMed ID: 30302596
[TBL] [Abstract][Full Text] [Related]
30. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
Kaufman BP; Alexis AF
J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study.
Lima EVA; Lima MMDA; Paixão MP; Miot HA
BMC Dermatol; 2017 Nov; 17(1):14. PubMed ID: 29183309
[TBL] [Abstract][Full Text] [Related]
32. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
[TBL] [Abstract][Full Text] [Related]
33. An Advanced, Physician-Strength Retinol Peel Improves Signs of Aging and Acne Across a Range of Skin Types Including Melasma and Skin of Color.
Sadick N; Edison BL; John G; Bohnert KL; Green B
J Drugs Dermatol; 2019 Sep; 18(9):918-923. PubMed ID: 31524348
[TBL] [Abstract][Full Text] [Related]
34. Response to narrow-band UVB--vitiligo-melasma versus vitiligo: a comparative study.
Sharma P; Pai HS; Pai GS; Kuruvila M; Kolar R
Am J Clin Dermatol; 2011 Apr; 12(2):127-32. PubMed ID: 21348543
[TBL] [Abstract][Full Text] [Related]
35. In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution.
Kang HY; Bahadoran P; Suzuki I; Zugaj D; Khemis A; Passeron T; Andres P; Ortonne JP
Exp Dermatol; 2010 Aug; 19(8):e228-33. PubMed ID: 20497220
[TBL] [Abstract][Full Text] [Related]
36. Treatment of melasma using fractional photothermolysis: a report of eight cases with long-term follow-up.
Katz TM; Glaich AS; Goldberg LH; Firoz BF; Dai T; Friedman PM
Dermatol Surg; 2010 Aug; 36(8):1273-80. PubMed ID: 20666816
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
Guevara IL; Pandya AG
Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
[TBL] [Abstract][Full Text] [Related]
38. Treatment of melasma with a low-fluence 1064 nm Q-switched Nd:YAG laser: Laser toning in Caucasian women.
Micek I; Pawlaczyk M; Kroma A; Seraszek-Jaros A; Urbańska M; Gornowicz-Porowska J
Lasers Surg Med; 2022 Mar; 54(3):366-373. PubMed ID: 34473361
[TBL] [Abstract][Full Text] [Related]
39. Lactic acid as a new therapeutic peeling agent in melasma.
Sharquie KE; Al-Tikreety MM; Al-Mashhadani SA
Dermatol Surg; 2005 Feb; 31(2):149-54; discussion 154. PubMed ID: 15762205
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and Safety Evaluation of Picosecond Alexandrite Laser with a Diffractive Lens Array for Treatment of Melasma in Asian Patients by VISIA Imaging System.
Chen YT; Lin ET; Chang CC; Lin BS; Chiang HM; Huang YH; Lin HY; Wang KY; Chang TM
Photobiomodul Photomed Laser Surg; 2019 Sep; 37(9):559-566. PubMed ID: 31411549
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
